Using TCGA gene expression data, we found that the AS3MT and PCCB genes were differentially expressed in breast cancer, and the expressions of SFXN2 and PCCB were significantly different in ovarian cancer (Figure S2A–D). This evidence concerns the gene SFXN2 and ovarian cancer.